Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
declares additional funding outside of this work by a Wellcome Trust Clinical Research Career Development Fellowship (224625/Z/21/Z)
:max_bytes(150000):strip_icc()/GettyImages-2198663639-d8b339f89d7f48bba50fdcf4ca56f835.jpg)
Uncharacterized long-term effects
FDA procedurally removed it from Category 2 in April 2026 after nominators withdrew their submissions and referred it to the Pharmacy Compounding Advisory Committee, which is scheduled to review it on July 23-24, 2026 for possible inclusion on the approved 503A bulks list
Clinical trial limitations No pineal peptide has undergone the rigorous Phase I through Phase III clinical trial process required for FDA approval
This unique structure allows it to act as a signaling molecule, carrying copper to cells and influencing their behavior
US$ 25.12
US$ 21.86
US$ 26.88
US$ 24.23
US$ 25.43
US$ 24.54
US$ 24.80
US$ 26.32
US$ 23.11
US$ 29.08
US$ 29.32
US$ 27.22
US$ 21.13
